Filing Details
- Accession Number:
- 0001192482-19-000430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 21:03:35
- Reporting Period:
- 2019-11-08
- Accepted Time:
- 2019-11-13 21:03:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561921 | Tela Bio Inc. | TELA | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1497725 | Quaker Bioventures Ii Lp | 150 Monument Road, Suite 207 Bala Cynwyd PA 19004 | No | No | Yes | No | |
1583083 | Quaker Bioventures Capital Ii, L.p. | 150 Monument Road, Suite 207 Bala Cynwyd PA 19004 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-08 | 153,846 | $13.00 | 888,664 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-11-13 | 345,489 | $0.00 | 1,234,153 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2019-11-13 | 516,947 | $0.00 | 1,751,100 | No | 4 | C | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2019-11-13 | 8,530,145 | $0.00 | 345,489 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2019-11-13 | 12,763,434 | $0.00 | 516,947 | $0.00 |
Series B Preferred Stock | Warrant (right to buy) | Disposition | 2019-11-13 | 446,813 | $0.00 | 446,813 | $1.16 |
Common Stock | Warrant (right to buy) | Disposition | 2019-11-13 | 446,813 | $0.00 | 18,096 | $28.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | 2017-01-18 | 2027-01-18 | No | 4 | C | Direct |
446,813 | 2019-11-13 | 2027-01-18 | No | 4 | C | Direct |
Footnotes
- Reflects 705,530 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a).
- Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date.
- Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019.
- Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering.